A novel strategy for treatment of bladder cancer: Antibody-drug conjugates [PDF]
Investigative and Clinical Urology, 2022 In the past, there was no second-line chemotherapeutic agent suitable for use when urothelial carcinoma (UC) progressed to platinum-resistant UC. However, recently, several new treatment options, such as immune checkpoint inhibitors or targeted therapy ...
Jung Hoon Kim, In Ho Chang
doaj +1 more source
Imaging DNA damage in vivo using γH2AX-targeted immunoconjugates
Cancer Research, 2011 DNA damage responses (DDRs) occur during oncogenesis and therapeutic responses to DNA damaging cytotoxic drugs. Thus, a real-time method to image DNA damage in vivo would be useful to diagnose cancer and monitor its treatment.
B. Cornelissen +7 more
semanticscholar +2 more sources
Antibody Conjugates for Sarcoma Therapy: How Far along Are We?
Biomedicines, 2021 Sarcomas are one of the most difficult type of cancer to manage and treat because of their extremely heterogeneous molecular and morphological features. Despite the progress made over the years in the establishment of standard protocols for high and low ...
Letizia Polito +5 more
doaj +1 more source
Synthesized Anti-HER2 Trastuzumab-MCC-DM1 Conjugate: An Evaluation of Efficacy and Cytotoxicity [PDF]
Iranian Journal of Immunology, 2023 Background: Trastuzumab is a humanized monoclonal antibody that targets site-specifically human epidermal growth factor-2 receptor (HER2) cell surface antigen overexpressed in approximately 20% of human breast carcinomas. Despite its positive therapeutic
Soodabeh Shafiee +5 more
doaj +1 more source
Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
Hemato, 2021 In the 2010s, immunotherapy revolutionized the treatment landscape of multiple myeloma. CD38-targeting antibodies were initially applied as monotherapy in end-stage patients, but are now also approved by EMA/FDA in combination with standards-of-care in ...
Christie P. M. Verkleij +3 more
doaj +1 more source
Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
Frontiers in Immunology, 2021 Although advances in antiretroviral therapy (ART) have significantly improved the life expectancy of people living with HIV-1 (PLWH) by suppressing HIV-1 replication, a cure for HIV/AIDS remains elusive.
Jeffrey C. Umotoy, Steven W. de Taeye
doaj +1 more source
Cancer Biotherapy and Radiopharmaceuticals, 2015 Astatine-211 is possibly the most promising radionuclide for targeted alpha-particle therapy when it comes to the treatment of occult disseminated cancer.
Emma Aneheim +5 more
semanticscholar +2 more sources
Vibrational spectroscopy as a tool for examination to the secondary structure of metal-labeled trastuzumab immunoconjugates [PDF]
Journal of Radioanalytical and Nuclear Chemistry, 2019 Infrared and Raman spectroscopy are effective techniques that allow collecting information about secondary structure of proteins, including antibodies.
M. Sterjova +5 more
semanticscholar +2 more sources
Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
Frontiers in Medicine, 2022 Targeted alpha therapy is an oncological treatment, where cytotoxic doses of alpha radiation are locally delivered to tumor cells, while the surrounding healthy tissue is minimally affected.
Roger M. Pallares +2 more
doaj +1 more source
Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer
Molecular Imaging, 2021 Background. Although therapeutic advances have led to enhanced survival in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, detection of residual disease remains challenging.
Solmaz AghaAmiri +8 more
doaj +1 more source